3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Advanced Solid Tumors
20
Carcinoma, Non-Small-Cell Lung
14
Myelodysplastic Syndromes
13
Breast Neoplasms
13
Advanced Solid Tumor
13
Recurrence
10
Ovarian Neoplasms
8
Neoplasms
8
Multiple Myeloma
8
Leukemia, Myelomonocytic, Chronic
8
Triple Negative Breast Neoplasms
7
Solid Tumor
6
Myeloproliferative Disorders
6
Small Cell Lung Carcinoma
5
Prostatic Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
5
Carcinoma, Hepatocellular
5
Advanced Solid Tumour
5
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Advanced Malignant Solid Tumor
4
Advanced Lung Cancer
4
Squamous Cell Carcinoma of Head and Neck
3
Interventions
Etoposide
7
Cisplatin
7
fludarabine
4
Cyclophosphamide
4
fludarabine phosphate
3
Paclitaxel
3
Carboplatin
3
Bleomycin
3
Automobiles
3
pembrolizumab
2
etoposide phosphate
2
Vorinostat
2
Sirolimus
2
Mesna
2
Ifosfamide
2
Drug Therapy
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
sodium thiosulfate
1
repotrectinib
1
pralsetinib
1
pegfilgrastim
1
lutetium Lu 177 dotatate
1
durvalumab
1
cabozantinib
1
Watchful Waiting
1
Teniposide
1
Surveys and Questionnaires
1
Stem Cell Transplantation
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Injections
×
1 year
×
Clear all
NCT02582697
2025-06-15
P3BEP
University of Sydney
Phase 3
Recruiting
500 enrolled